{"id":938672,"date":"2026-02-20T08:31:40","date_gmt":"2026-02-20T13:31:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/"},"modified":"2026-02-20T08:31:40","modified_gmt":"2026-02-20T13:31:40","slug":"srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/","title":{"rendered":"SRx Health Solutions Announces Receipt of Warning Letter from NYSE American"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NORTH PALM BEACH, Fla., Feb.  20, 2026  (GLOBE NEWSWIRE) &#8212; SRx Health Solutions, Inc. (NYSE American: SRXH) (the &#8220;Company&#8221;) today announced that on February 18, 2026, it received a public warning letter (the \u201cLetter\u201d) from the NYSE Regulation Staff of the New York Stock Exchange (the \u201cExchange\u201d) notifying the Company that it failed to comply with Sections 301 and 713 of the NYSE American LLC Company Guide (the \u201cCompany Guide\u201d).<\/p>\n<p>The Letter relates to the issuance of approximately 7.5 million shares (the \u201cSubject Shares\u201d) of the Company\u2019s common stock, par value $0.001 per share (the \u201cCommon Stock\u201d), between December 31, 2025 and January 23, 2026, upon conversion of certain shares of the Company\u2019s Series A Convertible Preferred Stock, par value $0.001 per share (the \u201cPreferred Shares\u201d). The Preferred Shares were issued pursuant to a Securities Purchase Agreement, dated October 27, 2025, by and among the Company and certain investors (the \u201cAgreement\u201d). The Agreement and the Preferred Shares are described in the Company\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission (the \u201cSEC\u201d) on October 31, 2025. Specifically, the Letter states that the Company failed to file an application to obtain the Exchange\u2019s listing approval for the issuance of additional shares of the Common Stock as required under Section 301 of the Company Guide and failed to obtain stockholder approval of an issuance that exceeded 20% of the Common Stock outstanding, as required under Section 713 of the Company Guide.<\/p>\n<p>The Company filed an application to obtain the Exchange\u2019s listing approval for the issuance of the Common Stock issuable upon conversion of the Preferred Shares on December 12, 2025. At the time of such filing, the conditions precedent to the conversion of the Preferred Shares under the Agreement had not been met and no shares of Common Stock had been issued in connection therewith.<\/p>\n<p>The Company obtained stockholder approval of the issuance of the Preferred Shares, and the issuance of the Common Stock upon the conversion thereof, including the potential for such issuance to exceed 20% of the Common Stock then-outstanding, by written consent of the stockholders on October 8, 2025. Such stockholder actions taken by written consent are described in the Company\u2019s Definitive Schedule 14C filed with the SEC on October 20, 2025. The Exchange has advised the Company that such stockholder approval was deficient under the Exchange\u2019s unpublished internal guidance on generic proxy proposals, which led to the violations set forth in the Letter.<\/p>\n<p>As of the date of this Current Report, all of the Preferred Shares have been either converted into Common Stock or redeemed by the Company, and no Preferred Shares are outstanding. Such redemption of Preferred Shares is described in the Company\u2019s Current Report on Form 8-K filed with the SEC on February 12, 2026.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as \u201cbelieve,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201caim,\u201d \u201cplan,\u201d \u201cmay,\u201d \u201ccould,\u201d \u201ctarget,\u201d and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company\u2019s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.<\/p>\n<p>\n        <strong>Company Contact<\/strong><br \/>\n        <br \/>SRx Health Solutions, Inc.<br \/>Kent Cunningham, Chief Executive Officer<\/p>\n<p>\n        <strong>Investor Relations Contact<\/strong><br \/>\n        <br \/>KCSA Strategic Communications<br \/>Valter Pinto, Managing Director<br \/>212-896-1254<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tk9aoeVXvvM5KJZ0IlEC_mYQwOBIvHIgO0H2NaL94u0-HwNNgM0hGh0Ptazw88zLoAFUjqkTfeGoDNctoUb2gg==\" rel=\"nofollow\" target=\"_blank\">valter@kcsa.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1ODE3NiM3NDM1ODgzIzIwOTg4MjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDE5ODE3MTYtNTQwNi00MzNkLTgxM2EtMDE5ZTJkOTAwZWViLTExMTAzOTEtMjAyNi0wMi0yMC1lbg==\/tiny\/SRx-Health-Solutions-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NORTH PALM BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) &#8212; SRx Health Solutions, Inc. (NYSE American: SRXH) (the &#8220;Company&#8221;) today announced that on February 18, 2026, it received a public warning letter (the \u201cLetter\u201d) from the NYSE Regulation Staff of the New York Stock Exchange (the \u201cExchange\u201d) notifying the Company that it failed to comply with Sections 301 and 713 of the NYSE American LLC Company Guide (the \u201cCompany Guide\u201d). The Letter relates to the issuance of approximately 7.5 million shares (the \u201cSubject Shares\u201d) of the Company\u2019s common stock, par value $0.001 per share (the \u201cCommon Stock\u201d), between December 31, 2025 and January 23, 2026, upon conversion of certain shares of the Company\u2019s Series A Convertible Preferred Stock, par value &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SRx Health Solutions Announces Receipt of Warning Letter from NYSE American&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-938672","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SRx Health Solutions Announces Receipt of Warning Letter from NYSE American - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SRx Health Solutions Announces Receipt of Warning Letter from NYSE American - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NORTH PALM BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) &#8212; SRx Health Solutions, Inc. (NYSE American: SRXH) (the &#8220;Company&#8221;) today announced that on February 18, 2026, it received a public warning letter (the \u201cLetter\u201d) from the NYSE Regulation Staff of the New York Stock Exchange (the \u201cExchange\u201d) notifying the Company that it failed to comply with Sections 301 and 713 of the NYSE American LLC Company Guide (the \u201cCompany Guide\u201d). The Letter relates to the issuance of approximately 7.5 million shares (the \u201cSubject Shares\u201d) of the Company\u2019s common stock, par value $0.001 per share (the \u201cCommon Stock\u201d), between December 31, 2025 and January 23, 2026, upon conversion of certain shares of the Company\u2019s Series A Convertible Preferred Stock, par value &hellip; Continue reading &quot;SRx Health Solutions Announces Receipt of Warning Letter from NYSE American&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-20T13:31:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1ODE3NiM3NDM1ODgzIzIwOTg4MjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SRx Health Solutions Announces Receipt of Warning Letter from NYSE American\",\"datePublished\":\"2026-02-20T13:31:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/\"},\"wordCount\":605,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1ODE3NiM3NDM1ODgzIzIwOTg4MjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/\",\"name\":\"SRx Health Solutions Announces Receipt of Warning Letter from NYSE American - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1ODE3NiM3NDM1ODgzIzIwOTg4MjA=\",\"datePublished\":\"2026-02-20T13:31:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1ODE3NiM3NDM1ODgzIzIwOTg4MjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1ODE3NiM3NDM1ODgzIzIwOTg4MjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SRx Health Solutions Announces Receipt of Warning Letter from NYSE American\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SRx Health Solutions Announces Receipt of Warning Letter from NYSE American - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/","og_locale":"en_US","og_type":"article","og_title":"SRx Health Solutions Announces Receipt of Warning Letter from NYSE American - Market Newsdesk","og_description":"NORTH PALM BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) &#8212; SRx Health Solutions, Inc. (NYSE American: SRXH) (the &#8220;Company&#8221;) today announced that on February 18, 2026, it received a public warning letter (the \u201cLetter\u201d) from the NYSE Regulation Staff of the New York Stock Exchange (the \u201cExchange\u201d) notifying the Company that it failed to comply with Sections 301 and 713 of the NYSE American LLC Company Guide (the \u201cCompany Guide\u201d). The Letter relates to the issuance of approximately 7.5 million shares (the \u201cSubject Shares\u201d) of the Company\u2019s common stock, par value $0.001 per share (the \u201cCommon Stock\u201d), between December 31, 2025 and January 23, 2026, upon conversion of certain shares of the Company\u2019s Series A Convertible Preferred Stock, par value &hellip; Continue reading \"SRx Health Solutions Announces Receipt of Warning Letter from NYSE American\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-20T13:31:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1ODE3NiM3NDM1ODgzIzIwOTg4MjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SRx Health Solutions Announces Receipt of Warning Letter from NYSE American","datePublished":"2026-02-20T13:31:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/"},"wordCount":605,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1ODE3NiM3NDM1ODgzIzIwOTg4MjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/","name":"SRx Health Solutions Announces Receipt of Warning Letter from NYSE American - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1ODE3NiM3NDM1ODgzIzIwOTg4MjA=","datePublished":"2026-02-20T13:31:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1ODE3NiM3NDM1ODgzIzIwOTg4MjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1ODE3NiM3NDM1ODgzIzIwOTg4MjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/srx-health-solutions-announces-receipt-of-warning-letter-from-nyse-american\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SRx Health Solutions Announces Receipt of Warning Letter from NYSE American"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/938672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=938672"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/938672\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=938672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=938672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=938672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}